Related Experiment Video

Updated: Jul 15, 2026

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
10:28

A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks

Published on: June 26, 2020

Epidemiology of severe hepatitis A in Indigenous Australian children

C Raina MacIntyre1, Margaret Burgess, David Isaacs

  • 1National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases (NCIRS), The Children's Hospital at Westmead and the University of Sydney, Sydney, NSW, Australia. rainam@chw.edu.au

Journal of Paediatrics and Child Health
|May 11, 2007
PubMed

Insights

Indigenous Australian children face a significantly higher risk of hepatitis A, especially those under five years old. This highlights the need for targeted vaccination programs to reduce disease burden.

Area of Science:

  • Epidemiology
  • Public Health
  • Infectious Diseases

Background:

  • Hepatitis A poses a significant health risk to Indigenous Australian children.
  • Understanding the epidemiology is crucial for effective public health interventions.

Purpose of the Study:

  • To describe the epidemiology of hepatitis A in Indigenous Australian children.
  • To establish baseline data for evaluating new vaccination programs.

Main Methods:

  • Analysis of national hepatitis A notification data.
  • Mapping of hospitalisation data across Australian jurisdictions.

Main Results:

  • Indigenous children, particularly aged 0-4 years, exhibit substantially higher hepatitis A notification and hospitalisation rates compared to non-Indigenous children.
  • Rates of hepatitis A morbidity decrease with age but remain elevated in Indigenous children up to 14 years.
  • Higher incidence observed in the Northern Territory, South Australia, Western Australia, and North Queensland.

Conclusions:

  • Indigenous children are disproportionately affected by hepatitis A, with the highest risk in early childhood.
  • Geographic mapping indicates a correlation between hepatitis A rates and Indigenous population density.
  • This study provides essential baseline data for assessing the impact of the 2005 hepatitis A vaccination program for Indigenous Australian children.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Amebiasis01:28

Amebiasis

Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...